Skip to content
Open access

Albuminuria and cumulative worsening heart failure events in the spanish cardiorenal registry

Nov 2026 · Clinical Kidney Journal · 0 citations

TL;DR

Elevated UACR independently predicts the cumulative burden of recurrent WHF in ambulatory chronic HF, with risk already detectable below the conventional 30 mg/g threshold, with risk increased continuously across the UACR spectrum with no threshold at 30 mg/g.

Abstract

Albuminuria reflects cardiorenal vulnerability and has been associated with adverse outcomes in heart failure (HF). However, its relationship with the total burden of recurrent worsening HF (WHF) events in ambulatory patients remains insufficiently defined. We conducted a prospective, multicenter cohort study including 940 ambulatory patients with chronic HF from the Spanish Cardiorenal Registry (derivation cohort) and externally validated the findings in 335 patients attending the Heart Failure Clinic of Hospital Clínico Universitario de Valencia, Valencia, Spain. UACR was measured at baseline and analyzed as <30 vs ≥30 mg/g and as a log-transformed continuous variable. The primary endpoint was total WHF events. Recurrent events were analyzed using negative binomial regression. In the derivation cohort (mean age 72 ± 13 years, 36.7% women), the median eGFR and UACR were 54 ml/min/1.73m² (IQR: 37–77) and 20 mg/g (IQR: 10–70), respectively, and 379 patients (40.3%) had UACR values ≥30 mg/g. During a median follow-up of 1.05 years, 477 WHF events occurred in 197 patients. After multivariable adjustment, UACR ≥30 mg/g independently predicted total WHF events (IRR 1.55; 95% CI 1.12–2.15; p = 0.009). Continuous analyses confirmed a graded, non-linear association across the UACR spectrum (p = 0.017). Risk increased continuously across the UACR spectrum with no threshold at 30 mg/g: compared with a UACR of 10 mg/g, a value of 25 mg/g, still within the conventional normal range, was associated with a higher rate of recurrent WHF events (IRR 1.10; 95% CI 1.03–1.18; p = 0.006). Consistent results were obtained in the validation cohort. Elevated UACR independently predicts the cumulative burden of recurrent WHF in ambulatory chronic HF, with risk already detectable below the conventional 30 mg/g threshold. Whether measuring UACR improves clinical decision-making requires prospective evaluation.

Read PDF

Similar papers

Open access Oct 2026

Post-discharge eGFR slope and mortality in acute heart failure with atrial fibrillation

The prognostic significance of longitudinal renal function decline remains underexplored in patients with acute heart failure (AHF) and atrial fibrillation (AF), in whom baseline renal dysfunction is common and risk stratification is challenging. To determine whether the post-discharge trajectory of estima...

J. Yamamoto, K. Nakamura, H. Hayama et al. · 0 citations
Open access Nov 2026

Chronic kidney disease in heart failure: results from an Ecuadorian registry.

Objectives Heart failure (HF) frequently coexists with chronic kidney disease (CKD), a combination that is associated with worse outcomes. Data from Ecuador remain limited. We estimated the prevalence of CKD among patients with HF and described prognostic impact according to left ventricular ejection fraction (LVEF)....

Ronald E. Pucha-Pesántez, Luis Moreno-Rondón, M. E. Ortega-Armas et al. · 0 citations
Open access Oct 2026

Beyond Cardiorenal Risk Factors: The Prognostic Role of Frailty in Acute Heart Failure

Background: Frailty is highly prevalent in acute heart failure (AHF), yet whether it is more strongly associated with all-cause mortality or with non-fatal heart-failure events, and whether it adds information beyond cardiac severity, is seldom examined. Methods: In a prospective single-center registry of 530 consecuti...

G. Aletras, M. Marketou, M. Bachlitzanaki et al. · 0 citations
Open access Nov 2026

Development and external validation of a nomogram incorporating the TyG index and prognostic nutritional index for predicting cardiovascular events in patients with heart failure with preserved ejection fraction and chronic kidney disease

Heart failure with preserved ejection fraction (HFpEF) frequently coexists with chronic kidney disease (CKD), representing a high-risk cardiorenal phenotype within the cardiovascular–kidney–metabolic (CKM) syndrome. Despite the high burden of adverse cardiovascular events in this population, dedicated risk predicti...

Feng Wang, Chuan-Peng Wang, Rui-Hao Jiang et al. · 0 citations
Open access Oct 2026

Improving outcomes in HFpEF with advanced CKD: temporal trends from the SHEBAHEART Registry

Patients with advanced chronic kidney disease (CKD) and heart failure (HF) are systematically underrepresented in clinical trials despite comprising a substantial proportion of real-world HF populations [1]. Whether contemporary care has translated into improved outcomes in this high-risk group particularly among...

D. Hochstein, D. Sternik, V. Copeland et al. · 0 citations
Open access Oct 2026

Sex differences in clinical phenotypes and prognostic associations in acute heart failure

Background Women are under-represented in heart failure trials, and the risk markers used in acute heart failure (AHF) derive largely from male-predominant cohorts. In this study, we compared the metabolic, inflammatory, and renal profiles of men and women hospitalized for AHF and tested whether the prognostic value of...

G. Aletras, M. Bachlitzanaki, Stylianos Fiflis et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.